Targeting biodefense markets

Research output: Contribution to journalArticlepeer-review


The World Vaccine Congress 2009 held in Washington D.C. (April 20-23, 2009) sponsored several sessions focused on the vaccine market targeting biodefense. On day one of the congress, a panel discussion outlined the federal progress in medical countermeasure preparedness that included emerging infections, influenza and biodefense focuses. The second session focused on the biodefense vaccine market with both government and industry members discussing the opportunities and challenges associated with the budding market.

Original languageEnglish (US)
Pages (from-to)660-665
Number of pages6
JournalHuman Vaccines
Issue number10
StatePublished - 2009
Externally publishedYes


  • Biodefense
  • Federal funding
  • Markets
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • General Pharmacology, Toxicology and Pharmaceutics


Dive into the research topics of 'Targeting biodefense markets'. Together they form a unique fingerprint.

Cite this